Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen

Urology
F LabrieM Lemay

Abstract

To determine the percentage of localized and potentially curable prostate cancers diagnosed at follow-up screening visits compared with the first screening visit. Within the context of a prospective screening study performed in randomly chosen men aged between 45 and 80 years, up to 6-year follow-up screening visits have been performed with serum prostate-specific antigen (PSA) measurement and digital rectal examination (DRE) followed by transrectal ultrasonography of the prostate when PSA or DRE is abnormal. Of the 117 prostate cancers diagnosed at 14,554 annual follow-up visits, only 1 cancer (0.9%) was metastatic compared with 8% (26/322) at 8029 first visits. Moreover, 97% of the cancers detected at follow-up visits could be identified by PSA alone compared with 86% at first visit. The incidence of 0.8% per year during 15 years of screening between the ages of 55 and 70 years would diagnose localized prostate cancer in 12% of the population, a value not too different from the 10% diagnosed with prostate cancer during life-time in the absence of screening. The present data show that annual screening with PSA diagnoses clinically localized prostate cancer in more than 95% of cases, thus almost completely eliminating the diagn...Continue Reading

References

Feb 1, 1992·British Journal of Urology·J AdolfssonT Löwhagen
Apr 25, 1991·The New England Journal of Medicine·W J CatalonaG L Andriole
Aug 17, 1989·The New England Journal of Medicine·E D CrawfordP J Goodman
Apr 30, 1988·Lancet·N J George
Dec 1, 1994·Scandinavian Journal of Urology and Nephrology·G AusL Norlén
Feb 1, 1995·Nature Medicine·S A NarodF Labrie
Jan 27, 1994·The New England Journal of Medicine·G W ChodakJ Warner

❮ Previous
Next ❯

Citations

Feb 15, 2001·The Journal of Urology·F D GillilandC R Key
Jun 7, 1997·Lancet·M FrydenbergK W Kaye
Feb 8, 2003·Molecular and Cellular Endocrinology·Fernand Labrie
Apr 1, 1997·British Journal of Urology·W M Garraway, F E Alexander
Jun 19, 2013·Asian Journal of Andrology·Fernand Labrie
Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Harry J de KoningUNKNOWN International Prostate Cancer Screening Trials Evaluation Group
May 13, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·Fernand Labrie
May 22, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Seyyed Yousof HosseiniMohammah Reza Safarinejad
Feb 9, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Fernand LabrieClaude Labrie
Mar 1, 1997·British Journal of Urology·U H Stenman
Feb 15, 2005·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Fernand Labrie
May 11, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M R Safarinejad
Feb 27, 2013·The Cochrane Database of Systematic Reviews·Dragan IlicPhilipp Dahm
Nov 13, 2003·Médecine sciences : M/S·Fernand LabrieJacques Simard
May 1, 2011·Expert Review of Endocrinology & Metabolism·Fernand Labrie
Jul 1, 1997·Annals of Clinical Biochemistry·M W France, C J Seneviratne
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tuukka MäkinenAnssi Auvinen
Apr 9, 2021·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wenyu WangLingzhi Gong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.